4
Total investments
0
Early stage
1
Mid stage
0
Late stage
10y
Years active
Portfolio
3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Private Investor
Jan 2022
Jameo is the easiest solution to create custom clothing with your team or group. We help teamwork make the dream work by creating highly personalized products that people will actually wear and love.
Experience · 4 entries
All (4)
Investments (4)
2022
Private Investor
Jan 2022
Jameo is the easiest solution to create custom clothing with your team or group. We help teamwork make the dream work by creating highly personalized products that people will actually wear and love.
2016
Private Investor
Jan 2016
IPA is a progressive, scientific Contract Research Organization (CRO) recently ranked by one of the pharmaceutical industry’s most trusted, independent market research sources with the highest competitive score, for its antibody service portfolio.1
The company represents a HUB of biotherapeutic intelligence that includes a hybrid of experts and technologies, in the science and business of bioplatform-based discovery. We provide highly specialized full-continuum therapeutic antibody discovery, development, and out-licensing services [Talem] —with advanced omics and complex intelligence technology [LENSai] that provide greater efficiency and accuracy than ever before.
Our mission is to provide our pharmaceutical customers with a HUB of the most advanced intelligence and technology to treat disease, bar none. Our goal — is to improve the specificity of biotherapeutics by unlocking the language of the genome.
1. ROOTS 2022: Antibody Discovery Services and Platforms Market (Industry Trends and Global Forecast, 4th Edition), 2021-2035; p.118
Investment activity
2016–2022 · 4 investments
Recent (last 2 years)Earlier